Q85.0
Neurofibromatosis (nonmalignant)
Clinical Classification Guidelines
Medical Intelligence & Overview
Neurofibromatosis (nonmalignant) is a genetic disorder characterized by the growth of benign tumors called neurofibromas along nerves throughout the body. These tumors develop from the cells surrounding nerve fibers and are typically noncancerous. The condition can affect various parts of the body, leading to a range of physical signs and potential complications. Although neurofibromas are generally benign, their presence and progression may necessitate medical attention for cosmetic concerns or associated symptoms. Neurofibromatosis can manifest at birth or develop during childhood or adolescence, with symptoms varying widely among individuals.
Causes & Symptoms
Clinical Causes: Genetic mutations in specific genes responsible for nerve cell growth regulation Inheritance pattern: autosomal dominant, meaning only one copy of the altered gene from an affected parent can cause the disorder De novo mutations occurring spontaneously in a family with no history of the disorder
Key Symptoms: Multiple soft, benign tumors (neurofibromas) on or under the skin Cafe-au-lait spots—light to dark brown skin patches that are often present at birth or develop in early childhood Freckles in unusual areas such as the armpits or groin Lisch nodules—tiny, harmless bumps on the iris of the eye Bone deformities, including scoliosis or bowing of bones Learning disabilities or developmental delays in some cases Optic pathway gliomas, which can affect vision Other neurological symptoms depending on tumor locations
Diagnostic & Treatment
Diagnosis Path: Diagnosing neurofibromatosis involves a combination of clinical evaluation and genetic testing. Healthcare providers typically assess physical features, such as the number and size of neurofibromas, presence of cafe-au-lait spots, and Lisch nodules. Imaging studies like MRI or CT scans can help identify deep or internal tumors. Genetic testing may be employed to detect mutations in specific genes associated with the disorder, aiding in confirmatory diagnosis especially in complicated or uncertain cases. Regular monitoring is often recommended to track tumor development and manage potential complications.
Treatment Protocols: There is no cure for neurofibromatosis; management focuses on monitoring and addressing symptoms and related health issues. Treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is Q85.0 a billable ICD-10 code?
Yes, Q85.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q85.0?
Clinical documentation must specify the nature of Neurofibromatosis (nonmalignant) and any associated comorbidities for accurate reporting.
Cite this Clinical Reference